miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
Authors
Keywords
-
Journal
Cancer Management and Research
Volume Volume 12, Issue -, Pages 12623-12633
Publisher
Informa UK Limited
Online
2020-12-08
DOI
10.2147/cmar.s276316
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Suppression of miR-21-3p enhances TRAIL-mediated apoptosis in liver cancer stem cells by suppressing PI3K/Akt/Bad cascade via regulating PTEN
- (2019) Yingwei Zhu et al. Cancer Management and Research
- miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway
- (2019) Bao Li et al. GENE
- Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
- (2019) Park et al. Cancers
- Long noncoding RNA FAM83A-AS1 facilitates hepatocellular carcinoma progression by binding with NOP58 to enhance the mRNA stability of FAM83A
- (2019) Jinyu He et al. BIOSCIENCE REPORTS
- CD44 promotes PD-L1 expression and its tumor-intrinsic function in breast and lung cancers
- (2019) Tim Kong et al. CANCER RESEARCH
- A FAM83A Positive Feed-back Loop Drives Survival and Tumorigenicity of Pancreatic Ductal Adenocarcinomas
- (2019) Neetha Parameswaran et al. Scientific Reports
- Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma
- (2019) Chen Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Catumaxomab with Activated T-cells Efficiently Lyses Chemoresistant EpCAM-positive Triple-negative Breast Cancer Cell Lines
- (2018) MAKOTO KUBO et al. ANTICANCER RESEARCH
- TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis
- (2018) Xiaodan Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
- (2018) Charissa Kim et al. CELL
- miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer
- (2018) Huaping Xiong et al. CELLULAR SIGNALLING
- Regulation of microRNA biogenesis and its crosstalk with other cellular pathways
- (2018) Thomas Treiber et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
- (2018) Mihriban Karaayvaz et al. Nature Communications
- MicroRNA-613 inhibits proliferation and invasion of renal cell carcinoma cells through targeting FZD7
- (2017) Haitao Song et al. Molecular Medicine Reports
- Tumor suppressor microRNA-613 inhibits glioma cell proliferation, invasion and angiogenesis by targeting vascular endothelial growth factor A
- (2017) Xiongwu Yu et al. Molecular Medicine Reports
- MicroRNA-613 inhibits the progression of gastric cancer by targeting CDK9
- (2017) Yebin Lu et al. Artificial Cells Nanomedicine and Biotechnology
- FAM83A is amplified and promotes cancer stem cell-like traits and chemoresistance in pancreatic cancer
- (2017) S Chen et al. Oncogenesis
- HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss
- (2017) Courtney A. Bartel et al. PLoS One
- EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune Surveillance
- (2016) Xiaohu Zheng et al. CANCER RESEARCH
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- USP16 Downregulation by Carboxyl-terminal Truncated HBx Promotes the Growth of Hepatocellular Carcinoma Cells
- (2016) Yu Qian et al. Scientific Reports
- FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice
- (2012) Sun-Young Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- FAM83B mediates EGFR- and RAS-driven oncogenic transformation
- (2012) Rocky Cipriano et al. JOURNAL OF CLINICAL INVESTIGATION
- Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer
- (2011) Yasuyo Ohi et al. HISTOPATHOLOGY
- CD44+/CD24−/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome
- (2011) Michael O. Idowu et al. HUMAN PATHOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More